Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

Healthcare Biotechnology

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc > Halted

<< Previous

Bullboard Posts

Next >>

Comment by inviolablspiriton Mar 26, 2024 1:37pm

58 Views

Post# 35953457

RE:RE:RE:Halted

If this little gem of a company can climb it's way up into dollarland then a listing on the NASDAQ would propel the stock up like MMED. We are a long ways off at the moment, but It's certainly possible with FDA approval and continued partnerships. Certainly worth holding and collecting.

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features